Towards safer medication practices: a retrospective analysis of adverse drug reactions
Under-reporting of adverse drug reactions (ADRs) to regulatory authorities remains a major challenge for pharmacovigilance, despite the substantial patient safety and financial implications of ADRs encountered in clinical practice. Reporting by healthcare professionals is persistently low; in 2017, only 19% of reports...